Clinical Trials Browser

NCT07308886 2026-03-19

Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)

Phase 2 Recruiting

55 enrolled

LymphoidSarcoma

Lymphoproliferative Disorders, Sarcoma, Kaposi

NCT05907759 2026-03-18

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Phase 2 Recruiting

28 enrolled

LymphoidSarcoma

Multi-centric Castleman's Disease, Lymphoma, Non-Hodgkin, Sarcoma, Kaposi, Lymphoma, Primary Effusion

NCT00000996 2021-11-04

A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma

Phase 2 Completed

48 enrolled

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00000687 2021-11-03

Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma

Phase 2 Completed

60 enrolled

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00001114 2021-11-01

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

Phase 2 Completed

90 enrolled

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00000807 2021-10-28

Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy

Phase 2 Completed

41 enrolled

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT01441063 2020-10-27

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Phase 2 Completed

8 enrolled 18 charts

LymphoidSarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Castleman Disease, Sarcoma, Kaposi

NCT00923936 2018-07-24

Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma

Phase 2 Completed

16 enrolled 13 charts

Sarcoma

Sarcoma, Kaposi

NCT00055237 2017-09-06

Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients

Phase 2 Completed

19 enrolled 10 charts

Sarcoma

Neoplasms, Sarcoma, Kaposi, HIV Infections

NCT00019240 2013-06-20

Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection

Phase 2 Completed

Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

NCT00295984 2013-06-20

Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma

Phase 2 Completed

24 enrolled

Sarcoma

Sarcoma, Sarcoma, Kaposi

NCT00020449 2013-06-19

Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Phase 2 Completed

Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

NCT00064142 2013-06-05

Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma

Phase 2 Completed

30 enrolled

Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi

NCT00001059 2012-04-17

Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

Phase 2 Completed

120 enrolled

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections